Sonelokimab
Product Specifications
CAS Number
1414386-05-2
Target
Interleukin|||MMP
Related Pathways
Proteases/Proteasome|||Immunology/Inflammation
Bioactivity
Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody combining monovalent camelid-derived nanobodies targeting human interleukin (IL) -17A and IL-17F with human serum albumin VHHs, presenting it as a promising candidate for investigating plaque-type psoriasis treatments [1] [2].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
